Charles River Laboratories

Yahoo Finance • 3 days ago

NYSE Content Update: Join Us and 6,500+ Attendees at Marquee AI Event HumanX

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, April 6, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE... Full story

Yahoo Finance • 4 days ago

Notable healthcare headlines for the week: Apellis, Centessa, and UnitedHealth in focus

Wall Street’s major market averages ended mixed on Thursday as markets assessed President Donald Trump’s address to the nation and the latest developments in the Middle East conflict. The tech-focused Nasdaq Composite finished +0.1%. At t... Full story

Yahoo Finance • 13 days ago

RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as investors reacted to escalating uncertainty tied to the U.S.-Iran conflict and poli... Full story

Yahoo Finance • 24 days ago

Charles River Laboratories International is Now Oversold (CRL)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the R... Full story

Yahoo Finance • 25 days ago

Notable healthcare headlines for the week: Eli Lilly, Novo Nordisk, and CVS Health in focus

Wall Street’s major indexes ended lower on Friday as investors digested a fresh batch of economic data, highlighted by the latest PCE inflation and GDP reports. The benchmark S&P 500 ended -0.6%, the blue-chip Dow closed -0.2%, and the te... Full story

Yahoo Finance • 29 days ago

Citi Flags Agilent Technologies, Cuts Icon PLC Target, and More

Quick Read Citi is positioning selectively across life sciences by favoring recovery names with clear catalysts while avoiding companies navigating accounting uncertainty, with Agilent’s pending Biocare deal removal expected to drive mult... Full story

Yahoo Finance • 30 days ago

Charles River Laboratories International (CRL) Gains on Strong Results and Resilient Drug Outsourcing Demand

Ariel Investments, an investment management company, released its "Ariel Appreciation Fund" fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund advanced +3.04% in the fourth quarter of 2025, outperfor... Full story

Yahoo Finance • last month

Charles River Laboratories International (CRL) Faces Biotech R&D Spending Headwinds

Invesco Ltd‘s “Small Cap Value Fund” released its Q4 2025 investor letter. A copy of the letter can be downloaded here. The Invesco Small Cap Value Fund reported strong results for Q4 2025, outperforming its Russell 2000 Value Index benchm... Full story

Yahoo Finance • last month

Notable healthcare headlines for the week: Viatris, Novo Nordisk, and Gilead Sciences in focus

Wall Street’s major market averages finished lower on Friday after the January wholesale inflation report came in hotter than expected. The blue-chip Dow was last lower by 1%, while the benchmark S&P 500 was -0.4%. At the same time, the t... Full story

Yahoo Finance • 2 months ago

Here are the major earnings before the open Wednesday

Major earnings expected before the bell on Wednesday include: * Analog Devices (ADI [https://seekingalpha.com/symbol/ADI]) * SolarEdge Technologies (SEDG [https://seekingalpha.com/symbol/SEDG]) * Fiverr International Ltd. (FVRR [htt... Full story

Yahoo Finance • 2 months ago

Analysts Are Bullish On Charles River Laboratories (CRL) Prospects

Charles River Laboratories International, Inc. (NYSE:CRL) is one of the 12 best mid cap AI stocks to buy according to hedge funds. Charles Rhyee, an analyst at TD Cowen, increased the firm’s price target on Charles River Laboratories Inter... Full story

Yahoo Finance • 4 months ago

Stocks Fall Ahead of US November Payroll Report

The S&P 500 Index ($SPX) (SPY) on Monday closed down by -0.16%, the Dow Jones Industrials Index ($DOWI) (DIA) closed down by -0.09%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down by -0.51%.  December E-mini S&P futures (ESZ25) fell -0... Full story

Yahoo Finance • 4 months ago

Stocks Climb in Anticipation of Fed-Friendly US Economic News

The S&P 500 Index ($SPX) (SPY) today is up by +0.39%, the Dow Jones Industrials Index ($DOWI) (DIA) is up by +0.27%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up by +0.50%.  December E-mini S&P futures (ESZ25) are up +0.40%, and December E... Full story

Yahoo Finance • 4 months ago

Stock index futures rise as focus turns to FOMC meeting

[Wall street.] bodrumsurf Stock index futures rose on Monday as investors positioned themselves ahead of Wednesday’s crucial Federal Reserve meeting. S&P 500 futures (SPX [https://seekingalpha.com/symbol/SPX]) edged higher by +0.08% to... Full story

Yahoo Finance • 4 months ago

What Makes Charles River Laboratories (CRL) an Investment Bet?

Madison Investments, an investment advisor, released its “Madison Small Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The third quarter was difficult for the Small Cap Fund.  The small-cap index... Full story

Yahoo Finance • 5 months ago

Cathie Wood's Ark Invest weekly recap: bets on AI-driven biotech, buys dip in CRCL, sells IRDM, PINS

[Bitcoin 2022 Conference Draws Cryptocurrency Industry Professionals And Investors To Miami] Marco Bello Cathie Wood’s ARK Invest reported a mixed week of aggressive buying in AI, biotech, and digital-asset infrastructure names, while con... Full story

Yahoo Finance • 5 months ago

Charles River Laboratories Updates FY25 Earnings Outlook

(RTTNews) - Charles River Laboratories International, Inc. (CRL), Wednesday an updated financial outlook for fiscal year 2025. The company now anticipates earnings of $4.15 - $4.35 per share, instead of previously estimated $4.25 - $4.65... Full story

Yahoo Finance • 5 months ago

Charles River Laboratories International Inc. Q3 Profit Decreases, But Beats Estimates

(RTTNews) - Charles River Laboratories International Inc. (CRL) announced earnings for third quarter that decreased from the same period last year but beat the Street estimates. The company's bottom line came in at $68.68 million, or $1.... Full story

Yahoo Finance • 5 months ago

Charles River Laboratories’s (NYSE:CRL) Q3: Beats On Revenue

Lab services company Charles River Laboratories (NYSE:CRL) announced better-than-expected revenue in Q3 CY2025, but sales were flat year on year at $1.00 billion. Its non-GAAP profit of $2.43 per share was 3.9% above analysts’ consensus es... Full story

Yahoo Finance • 5 months ago

Charles River Laboratories Provides Update on Strategic Review

–Announces Steps to Strengthen and Refine Portfolio and to Maximize Financial Performance – WILMINGTON, Mass., November 05, 2025--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced an update on its... Full story